Promising Covid-19 treatment based on silencing RNA and Nano particle developed by Australia and US scientists
Traditional antivirals, which include Tamiflu, zanamivir and remdesivir, reduce symptoms and help people recover earlier. The new antiviral approach used gene-silencing RNA technology called siRNA (small-interfering RNA) to attack the virus' genome directly, which stops the virus from replicating, as well as lipid nanoparticles designed at Griffith University and City of Hope to deliver the siRNA to the lungs, the critical site of infection. It was used on mice. "Treatment with virus-specific siRNA reduces viral load by 99.9 per cent. These stealth nanoparticles can be delivered to a wide range of lung cells and silence viral genes," said co-lead researcher Nigel McMillan, Professor at Menzies Health Institute Queensland (MHIQ) at Griffith. Ref https://www.businessinsider.in/science/health/news/scientists-from-australia-and-us-develops-new-antiviral-therapy-with-99-99-efficacy-against-covid-19/articleshow/82766246.cms